1-6 of 6
Sherif S Farag, MD, PhD
Close
Sort by
Journal Articles

Inhibition of PIM Kinases Mitigates DNA Repair Responses Following Anthracycline-Induced DNA Damage and Enhances the Anti-Tumor Activity of Doxorubicin Against Lymphoma Cells

Jeffrey D. Altenburg, PhD, Shuhong Zhang, PhD, Michelle Grimard, Xingkui Xue, MD PhD, Sherif S Farag, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4505.
https://doi.org/10.1182/blood.V124.21.4505.4505
Published: 2014
Journal Articles

The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo , and Shows Synergistic Activity in Combination with Lenalidomide

Xiaojing Wang, PhD, Anthony L. Sinn, Attaya Suvannasankha, MD, Colin D. Crean, Li Chen, MD, Shuhong Zhang, PhD, Jing Liang, MD, Genglin Zhang, Karen E. Pollok, PhD, Rafat Abonour, MD, Carolyn Sidor, MD, Mark R. Bray, PhD, Sherif S. Farag, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3660.
https://doi.org/10.1182/blood.V112.11.3660.3660
Published: 2008
Journal Articles

Synergistic Activity of Bendamustine in Combination with Doxorubicin and Bortezomib in Multiple Myeloma Cells

Shuhong Zhang, PhD, Xiaojing Wang, PhD, Li Chen, Jing Liang, Attaya Suvannasankha, MD, Rafat Abonour, MD, Sherif S Farag, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5171.
https://doi.org/10.1182/blood.V112.11.5171.5171
Published: 2008
Journal Articles

OSU03012, a Novel Celecoxib Derivative, Induces Apoptosis in Multiple Myeloma Cells Independently of Caspase Activation.

Shuhong Zhang, PhD, Valerie L. White, Amy Johnson, PhD, Ching-Shih Chen, PhD, Sherif S. Farag, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5075.
https://doi.org/10.1182/blood.V108.11.5075.5075
Published: 2006
Journal Articles

OSU-HDAC42, a Novel Histone Deacetylase Inhibitor, Induces Apoptosis in a Caspase-Dependent Manner and Induces p 21WAF1/CIP1 and p16 Expression in Multiple Myeloma Cell Lines.

Valerie L. White, Shuhong Zhang, PhD, David Lucas, PhD, Ching-Shih Chen, PhD, Sherif S. Farag, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5078.
https://doi.org/10.1182/blood.V108.11.5078.5078
Published: 2006
Journal Articles

Flavopiridol, Fludarabine and Rituximab Is a Highly Active Regimen in Indolent B-Cell Lymphoproliferative Disorders Including Mantle Cell Lymphoma.

Thomas S. Lin, MD, PhD, Beth Fischer, RN, Mollie E. Moran, RN, CNP, Maureen M. Buckner, RN, CNP, Roshini Shank, BS, Eric H. Kraut, MD, Pierluigi Porcu, MD, Sherif S. Farag, MD, PhD, Charles F. Eisenbeis, MD, PhD, Dimitrios Colevas, MD, Michael R. Grever, MD, John C. Byrd, MD
Journal: Blood
Blood (2005) 106 (11): 944.
https://doi.org/10.1182/blood.V106.11.944.944
Published: 2005